Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of RTS,S Hepatitis B Antigen in Infants
NCT01345240Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2011
- Primary completion
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of RTS,S in hepatitis B (HBV), malaria, sponsored by GSK. Started Nov 2011; status: completed.
02
Drugs
RTS,S
03
Conditions
hepatitis B (HBV)malaria
Beyond the preview
Go deeper on NCT01345240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345240.